Balyasny Asset Management
SBRA icon

Balyasny Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Balyasny Asset Management’s Portfolio SBRA Stock Details SBRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-150,000
Closed -$1.64M – 1449
2020
Q1 		$1.64M Buy
+150,000
New +$2.77M 0.02% 654

Other funds holding SBRA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Balyasny Asset Management's SBRA Position: Q1 2026 in Review

Balyasny Asset Management reduced its Sabra Healthcare REIT (SBRA) stake by 99% in Q1 2026, selling an estimated $37.5M and leaving 14,004 shares worth $269K. The position accounts for ﹤0.01% of the portfolio, ranked #2603.

Balyasny Asset Management first reported a position in SBRA in Q2 2013 and has held it in 28 quarters since. The position peaked at $50M in Q2 2025. 459 funds tracked by Wall St. Rank hold SBRA as of Q1 2026.

  • Balyasny Asset Management held 14,004 shares of Sabra Healthcare REIT worth $269K as of Q1 2026.
  • Balyasny Asset Management sold 1,902,251 Sabra Healthcare REIT shares in Q1 2026, an estimated $37.5M.
  • Sabra Healthcare REIT made up ﹤0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #2603 holding.
  • Balyasny Asset Management first reported a position in Sabra Healthcare REIT in Q2 2013 and has held it in 28 quarters since.
  • Balyasny Asset Management's Sabra Healthcare REIT position peaked at $50M in Q2 2025.
  • 459 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.